# A Study to Assess NEU-111 in Healthy Participants

> **NCT06500442** · PHASE1 · COMPLETED · sponsor: **Neuron23 Inc.** · enrollment: 64 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NEU-111
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06500442
- **Lead sponsor:** Neuron23 Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-17
- **Primary completion:** 2025-02-22
- **Final completion:** 2025-02-22
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06500442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06500442, "A Study to Assess NEU-111 in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06500442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*